A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant Pain

Completed · Phase 3 · Has a placebo group

Conditions studied: Opioid-Induced Constipation

In brief

MNTX 3201 is a Phase 3, international, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of oral MNTX for the treatment of opioid induced constipation in participants with chronic, non-malignant pain.

Key facts

Study ID
NCT01186770
Run by
Bausch Health Americas, Inc.
People needed
804
Starts
2010-09-01
Expected to finish
2011-09-08
Last updated by the study team
2019-09-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.